Skip to content

Scientific Venture Partners

Entrepreneurs co-founding and building companies
with groundbreaking science and the potential to change the world

We have:

worked together over the past 10 years to found, manage and build science-backed companies, delivering disruptive products into large global market opportunities in healthcare, security and communications

We co-founded

Balancing the microbiome to improve digestive health
Communication networks designed for beautiful urban landscapes, delivering 5G in style
Sensors for automated detection of concealed threats at a distance
Toolkits for new insights into personalized medicine in oncology and neurodegenerative disease
First clinically proven treatment for dysphagia
Diagnostics assays to further our understanding of disease
Artificial intelligence solutions for enhanced public safety

Acquired by Perkin Elmer

Rapid detection of bacteria for improved food safety
Nutritional products to improve animal health & performance

We are:

Vito Levi D’Ancona

Linkedin

Will Addison

Linkedin

Fred Edenius

Linkedin

Douglas Dundonald

Linkedin

We look for:

  • opportunities to make a difference and an impact
  • ground breaking science
  • defensible intellectual property
  • large market opportunities
  • financial rewards for all stakeholders

We do:

we found companies:

  • identify problems that we are passionate about, that can be addressed with proprietary technology, to exploit fast-growing global market opportunities
  • tap into our networks to validate the approach and latest state of the art attempts to solve the problem
  • assemble technologies, team and commercialisation pathways to deliver successful solutions

we build companies until exit:

  • as co-founders, provide the entrepreneurial drive & strategic direction behind our businesses
  • fill board, CEO and other executive roles as the companies grow and typically play an integral role in exits
  • invest personal capital and raise funds from our investor network

We believe in:

Stakeholder alignment:

We’ve learnt the importance of aligning the interests of founders, investors, management and prospective partners. Aligned interests help all parties pull in the same direction and maintain their motivation even in difficult times - providing the best chance of a successful outcome for all stakeholders.

Learning from both success and failure:

As founders and company builders, we’ve worked together for over 10 years and experienced much success and at times failure. As much as the successes are rewarding, the failures hurt. We constantly strive as a group to bring our collective experience in all that we do, across our companies, when needed.

The value of networks:

We’ve built and continue to cultivate a strong ecosystem of global scientific and managerial talent, academic, corporate and government networks, as well as diverse sources of capital. This ecosystem helps us assess scientific and market potential, facilitates the progress and growth of our businesses, and mitigates many of the risks inherent in building and growing disruptive technology companies.

The right capital for the right stage:

While businesses need appropriate resources to maximise chances of success, we emphasise capital efficiency, especially in a company’s early stages. Value accretive milestones must be clearly defined and pursued with laser focus. It is better to fail quickly and efficiently and then rethink the solution. Once the technology is de-risked, businesses will demand greater levels of capital, but having the right capital for the right stage is key.

Relentless enthusiasm:

We bring an enthusiastic disposition, energy and ‘can do’ approach – invaluable intangible assets for growing exciting young companies with bold ambitions.

We are based in:

London, UK and Boston, USA

Our London office is at:

The Royal Institution of Great Britain

21 Albemarle Street
London
W1S 4BS
United Kingdom